Rationally designed peptoids modulate aggregation of amyloid-beta 40

ACS Chemical Neuroscience

Volumn 5, Issue 7, 2014, Pages 552-558

  Turner, J Phillip ^a   Lutz Rechtin, Tammy ^a   Moore, Kelly A ^b,c   Rogers, Lauren ^a   Bhave, Omkar ^a   Moss, Melissa A ^b   Servoss, Shannon L ^a  

^a University of Arkansas   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

aggregates; Alzheimer's disease; amyloid beta; inhibitor; KLVFF; peptoid

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AROMATIC COMPOUND; KLVFF PROTEIN; PEPTOID; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (16-20); PEPTIDE FRAGMENT; THIAZOLE DERIVATIVE; THIOFLAVINE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; DEMENTIA; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; BINDING COMPETITION; CHEMISTRY; CIRCULAR DICHROISM; FLUORESCENCE; IMMUNOBLOTTING; TIME;

AMYLOID BETA-PEPTIDES; BINDING, COMPETITIVE; CIRCULAR DICHROISM; FLUORESCENCE; IMMUNOBLOTTING; PEPTIDE FRAGMENTS; PEPTOIDS; PROTEIN STRUCTURE, SECONDARY; THIAZOLES; TIME FACTORS;

EID: 84904439283     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400221u     Document Type: Article

References (45)

1. Hardy, J. and Selkoe, D. J. (2002) The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics Science 297, 353-356 (Pubitemid 34790756)
2. Etienne, M. A., Edwin, N. J., Aucoin, J. P., Russo, P. S., McCarley, R. L., and Hammer, R. P. (2007) Beta-Amyloid Protein Aggregation Methods Mol. Biol. 386, 203-225
3. Caughey, B. and Lansbury, P. T. (2003) Protofibrils, Pores, Fibrils, and Neurodegeneration: Separating the Responsible Protein Aggregates from the Innocent Bystanders Annu. Rev. Neurosci. 26, 267-298 (Pubitemid 37064935)
4. Glabe, C. G. (2006) Common Mechanisms of Amyloid Oligomer Pathogenesis in Degenerative Disease Neurobiol. Aging 27, 570-575 (Pubitemid 43290525)
5. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid Beta-Protein Assembly and Alzheimer Disease J. Biol. Chem. 284, 4749-4753
6. Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of Beta-Amyloid Fibril Formation by a Pentapeptide Ligand J. Biol. Chem. 271, 8545-8548 (Pubitemid 26123269)
7. Tjernberg, L. O., Lilliehöök, C., Callaway, D. J., Näslund, J., Hahne, S., Thyberg, J., Terenius, L., and Nordstedt, C. (1997) Controlling Amyloid Beta-Peptide Fibril Formation with Protease-Stable Ligands J. Biol. Chem. 272, 12601-12605 (Pubitemid 27203354)
8. Esler, W. P., Stimson, E. R., Ghilardi, J. R., Lu, Y. A., Felix, A. M., Vinters, H. V., Mantyh, P. W., Lee, J. P., and Maggio, J. E. (1996) Point Substitution in the Central Hydrophobic Cluster of a Human Beta-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence Biochemistry 35, 13914-13921 (Pubitemid 26374462)
9. Lowe, T. L., Strzelec, A., Kiessling, L. L., and Murphy, R. M. (2001) Structure-Function Relationships for Inhibitors of Beta-Amyloid Toxicity Containing the Recognition Sequence KLVFF Biochemistry 40, 7882-7889 (Pubitemid 32622980)
10. Watanabe, K., Nakamura, K., Akikusa, S., Okada, T., Kodaka, M., Konakahara, T., and Okuno, H. (2002) Inhibitors of Fibril Formation and Cytotoxicity of Beta-Amyloid Peptide Composed of KLVFF Recognition Element and Flexible Hydrophilic Disrupting Element Biochem. Biophys. Res. Commun. 290, 121-124 (Pubitemid 34694473)
11. Moss, M. A., Nichols, M. R., Reed, D. K. I. M., Hoh, J. A. N. H., and Rosenberry, T. L. (2003) The Peptide KLVFF-K 6 Promotes β-Amyloid (1-40) Protofibril Growth by Association but Does Not Alter Protofibril Effects on Diphenyltetrazolium Bromide (MTT) Mol. Pharmacol. 64, 1160-1168 (Pubitemid 37310749)
12. Hamley, I. W., Castelletto, V., Moulton, C. M., Rodríguez- Pérez, J., Squires, A. M., Eralp, T., Held, G., Hicks, M. R., and Rodger, A. (2010) Alignment of a Model Amyloid Peptide Fragment in Bulk and at a Solid Surface J. Phys. Chem. B 114, 8244-8254
13. Aileen Funke, S. and Willbold, D. (2012) Peptides for Therapy and Diagnosis of Alzheimer's Disease Curr. Pharm. Des. 18, 755-767
14. Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., and Moos, W. H. (1995) Comparison of the Proteolytic Susceptibilities of Homologous l -Amino Acid, d -Amino Acid, and N-Substituted Glycine Peptide and Peptoid Oligomers Drug Dev. Res. 35, 20-32
15. Zuckermann, R. N., Kerr, J. M., Kent, B. H., and Moos, W. H. (1992) Efficient Method for the Preparation of Peptoids [Oligo(N-Substituted Glycines)] by Submonomer Solid-Phase Synthesis J. Am. Chem. Soc. 114, 10646-10647
16. Kirshenbaum, K., Zuckermann, R. N., and Dill, K. A. (1999) Designing Polymers That Mimic Biomolecules Curr. Opin. Struct. Biol. 9, 530-535 (Pubitemid 29377899)
17. Barron, A. E. and Zuckermann, R. N. (1999) Bioinspired Polymeric Materials: In-between Proteins and Plastics Curr. Opin. Chem. Biol. 3, 681-687
18. Armand, P., Kirshenbaum, K., Falicov, A., Dunbrack, R. L., Dill, K. A., Zuckermann, R. N., and Cohen, F. E. (1997) Chiral N-Substituted Glycines Can Form Stable Helical Conformations Folding Des. 2, 369-75 (Pubitemid 127740561)
19. Armand, P., Kirshenbaum, K., Goldsmith, R. A., Farr-Jones, S., Barron, A. E., Truong, K. T. V, Dill, K. A., Mierke, D. F., Cohen, F. E., Zuckermann, R. N., and Bradley, E. K. (1998) NMR Determination of the Major Solution Conformation of a Peptoid Pentamer with Chiral Side Chains Proc. Natl. Acad. Sci. U.S.A. 95, 4309-4314 (Pubitemid 28207908)
20. Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P., Bradley, E. K., Truong, K. T. V, Dill, K. A., Cohen, F. E., and Zuckermann, R. N. (1998) Sequence-Specific Polypeptoids: A Diverse Family of Heteropolymers with Stable Secondary Structure Proc. Natl. Acad. Sci. U.S.A. 95, 4303-4308 (Pubitemid 28207907)
21. Wu, C. W., Sanborn, T. J., Zuckermann, R. N., and Barron, A. E. (2001) Peptoid Oligomers with Alpha-Chiral, Aromatic Side Chains: Effects of Chain Length on Secondary Structure J. Am. Chem. Soc. 123, 2958-2963 (Pubitemid 32879565)
22. Wu, C. W., Sanborn, T. J., Huang, K., Zuckermann, R. N., and Barron, A. E. (2001) Peptoid Oligomers with Alpha-Chiral, Aromatic Side Chains: Sequence Requirements for the Formation of Stable Peptoid Helices J. Am. Chem. Soc. 123, 6778-6784 (Pubitemid 32884537)
23. Sanborn, T. J., Wu, C. W., Zuckermann, R. N., and Barron, A. E. (2002) Extreme Stability of Helices Formed by Water-Soluble Poly-N-Substituted Glycines (polypeptoids) with Alpha-Chiral Side Chains Biopolymers 63, 12-20 (Pubitemid 34076032)
24. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., and Marlowe, C. K. (1992) Peptoids: A Modular Approach to Drug Discovery Proc. Natl. Acad. Sci. U.S.A. 89, 9367-9371
25. Chen, X., Wu, J., Luo, Y., Liang, X., Supnet, C., Kim, M. W., Lotz, P., Yang, G., Muchowski, P. J., Kodadek, T., and Bezprozvanny, I. (2012) Expanded Polyglutamine-Binding Peptoid as a Novel Therapeutic Agent for Treatment of Huntington's Disease J. Biol. Chem. 18, 1113-1125
26. Luo, Y., Vali, S., Sun, S., Chen, X., Liang, X., Drozhzhina, T., Popugaeva, E., and Bezprozvanny, I. (2013) Aβ42-Binding Peptoids as Amyloid Aggregation Inhibitors and Detection Ligands ACS Chem. Neurosci. 4, 952-962
27. Gao, C. M., Yam, A. Y., Wang, X., Magdangal, E., Salisbury, C., Peretz, D., Zuckermann, R. N., Connolly, M. D., Hansson, O., Minthon, L., Zetterberg, H., Blennow, K., Fedynyshyn, J. P., and Allauzen, S. (2010) Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease PLoS One 5, e15725
28. Zuckermann, R. N. and Kodadek, T. (2009) Peptoids as Potential Therapeutics Curr. Opin. Mol. Ther. 11, 299-307
29. Cho, S., Choi, J., Kim, A., Lee, Y., and Kwon, Y.-U. (2010) Efficient Solid-Phase Synthesis of a Series of Cyclic and Linear Peptoid-Dexamethasone Conjugates for the Cell Permeability Studies J. Comb. Chem. 12, 321-326
30. Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castaño, E. M., and Frangione, B. (1998) Beta-Sheet Breaker Peptides Inhibit Fibrillogenesis in a Rat Brain Model of Amyloidosis: Implications for Alzheimer's Therapy Nat. Med. 4, 822-826 (Pubitemid 28331024)
31. Sigurdsson, E. M., Permanne, B., Soto, C., Wisniewski, T., and Frangione, B. (2000) In Vivo Reversal of Amyloid-Beta Lesions in Rat Brain J. Neuropathol. Exp. Neurol. 59, 11-17 (Pubitemid 30069221)
32. Adessi, C., Frossard, M.-J., Boissard, C., Fraga, S., Bieler, S., Ruckle, T., Vilbois, F., Robinson, S. M., Mutter, M., Banks, W. A., and Soto, C. (2003) Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease J. Biol. Chem. 278, 13905-13911 (Pubitemid 36799931)
33. Poduslo, J., Curran, G., Kumar, A., Frangione, B., and Soto, C. (1999) Beta-Sheet Breaker Peptie Inhibitor of Alzheimer's Amyloidogenesis with Increased Blood-Brain Barrier Permeability and Resistance to Proteolytic Degradation in Plasma J. Neurobiol. 39, 371-382 (Pubitemid 29239200)
34. Hudson, S. a, Ecroyd, H., Kee, T. W., and Carver, J. a. (2009) The Thioflavin T Fluorescence Assay for Amyloid Fibril Detection Can Be Biased by the Presence of Exogenous Compounds FEBS J. 276, 5960-5972
35. Pike, C. J., Overman, M. J., and Cotman, C. W. (1995) Amino-Terminal Deletions Enhance β-Amyloid Peptides in Vitro J. Biol. Chem. 270, 23895-23898
36. Rosenman, D. J., Connors, C. R., Chen, W., Wang, C., and García, A. E. (2013) Aβ Monomers Transiently Sample Oligomer and Fibril-like Configurations: Ensemble Characterization Using a Combined MD/NMR Approach J. Mol. Biol. 425, 3338-3359
37. Wong, H. E., Qi, W., Choi, H. M., Fernandez, E. J., and Kwon, I. (2011) A Safe, Blood-Brain Barrier Permeable Triphenylmethane Dye Inhibits Amyloid-B Neurotoxicity by Generating Nontoxic Aggregates ACS Chem. Neurosci. 2, 645-657
38. Irwin, J. A., Wong, H. E., and Kwon, I. (2013) Different Fates of Alzheimer's Disease Amyloid-B Fibrils Remodeled by Biocompatible Small Molecules Biomacromolecules 14, 264-274
39. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. G. (2007) Fibril Specific, Conformation Dependent Antibodies Recognize a Generic Epitope Common to Amyloid Fibrils and Fibrillar Oligomers That Is Absent in Prefibrillar Oligomers Mol. Neurodegener. 2, 18
40. Wu, W., Liu, Q., Sun, X., Yu, J., Zhao, D., Yu, Y., Luo, J., Hu, J., Yu, Z., Zhao, Y., and Li, Y. (2013) Fibrillar Seeds Alleviate Amyloid-B Cytotoxicity by Omitting Formation of Higher-Molecular-Weight Oligomers Biochem. Biophys. Res. Commun. 439, 321-326
41. Yam, A. Y., Wang, X., Gao, C. M., Connolly, M. D., Zuckermann, R. N., Bleu, T., Hall, J., Fedynyshyn, J. P., Allauzen, S., Peretz, D., and Salisbury, C. M. (2011) A Universal Method for Detection of Amyloidogenic Misfolded Proteins Biochemistry 50, 4322-4329
42. Patch, J. A., Kirshenbaum, K., Seurynck, S. L., Zuckermann, R. N., and Barron, A. E. (2004) Versatile Oligo(N-Substituted) Glycines: The Many Roles of Peptoids in Drug Discovery. In Pseudo-Peptides in Drug Development (Nielsen, P.E., Ed.), pp 1-31, Wiley-VCH, Weinheim.
43. Ross, T. M., Zuckermann, R. N., Reinhard, C., and Frey, W. H. (2008) Intranasal Administration Delivers Peptoids to the Rat Central Nervous System Neurosci. Lett. 439, 30-33
44. Findeis, M. a, Musso, G. M., Arico-Muendel, C. C., Benjamin, H. W., Hundal, a M., Lee, J. J., Chin, J., Kelley, M., Wakefield, J., Hayward, N. J., and Molineaux, S. M. (1999) Modified-Peptide Inhibitors of Amyloid Beta-Peptide Polymerization Biochemistry 38, 6791-800
45. Austen, B. M., Paleologou, K. E., Ali, S. A. E., Qureshi, M. M., Allsop, D., and El-agnaf, O. M. A. (2008) Designing Peptide Inhibitors for Oligomerization and Toxicity of Alzheimer's Biochemistry 47, 1984-1992 (Pubitemid 351287124)